Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Formaldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde up-regulates the expression of DME CYP4F12 |
[1] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME CYP4F12 |
[2] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME CYP4F12 |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Senecionine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01585
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Senecionine inhibits the expression of DME CYP4F12 |
[4] |
Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Jinfukang |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Traditional Medicine |
DME Modulation |
Jinfukang up-regulates the expression of DME CYP4F12 |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME CYP4F12 |
[6] |
Avobenzone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00411
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Avobenzone inhibits the expression of DME CYP4F12 |
[7] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME CYP4F12 |
[8] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME CYP4F12 |
[2], [9] |
Ketoconazole |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Ketoconazole inhibits the drug-metabolizing activity of DME CYP4F12 |
[10] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Ethanol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol up-regulates the expression of DME CYP4F12 |
[11] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 up-regulates the expression of DME CYP4F12 |
[12] |
|
|
|
|
|
|